Insider Transactions in Q2 2022 at Adverum Biotechnologies, Inc. (ADVM)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 23
2022
|
Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER |
BUY
Open market or private purchase
|
Direct |
20,000
+49.26%
|
$0
$0.84 P/Share
|
|
May 17
2022
|
Richard Beckman Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$0
$0.82 P/Share
|
|
May 17
2022
|
Rupert D'Souza Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+32.41%
|
$0
$0.83 P/Share
|
|
May 16
2022
|
Dawn Svoronos |
BUY
Open market or private purchase
|
Direct |
30,000
+37.5%
|
$0
$0.85 P/Share
|
|
May 13
2022
|
Rupert D'Souza Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+47.96%
|
$0
$0.86 P/Share
|
|
Apr 20
2022
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
BUY
Open market or private purchase
|
Direct |
25,000
+3.17%
|
$25,000
$1.11 P/Share
|
|
Apr 19
2022
|
Peter Soparkar CHIEF OPERATING OFFICER |
BUY
Open market or private purchase
|
Direct |
21,925
+3.63%
|
$21,925
$1.14 P/Share
|